NCT05909878

Brief Summary

Background: Magnetic resonance imaging (MRI) has been known for almost forty years to generate fear and anxiety. Children may become restless during scanning, which results in movement artifacts requiring the MRI to be repeated with sedation. Very few studies seemed to have looked at the effect of immersive virtual reality (IVR) on anxiety in children scheduled for an MRI. Objectives: The aims of this study are two-fold: 1- to address feasibility and acceptability of a pre-procedural immersive VR (IVR) game preparation for anxiety management during MRIs and 2- to examine the efficacy of IVR game preparation compared to usual care for the management of procedural anxiety during MRIs. Methods: This study will first consist of a field test phase with 10 participants, aged 7 to 17 years old, to address the feasibility and acceptability of the use of virtual reality. Following the field test, a RCT will be completed using a parallel design with two groups: 1) experimental group (pre-procedural IVR game preparation), 2) usual care group (standard care as per radiology department's protocol) in an equal ratio of 49 participants per group for a total of 98 participants. Recruitment will be done at CHU Sainte-Justine's, Quebec, Canada. The experimental group will receive a pre-procedural IVR game preparation (IMAGINE) that offers an immersive simulation of the MRI. Participants will complete a questionnaire to assess the acceptability, feasibility and incidence of side effects related to the intervention and the biofeedback device. Data collected will include socio-demographic, clinical characteristics, measures of anxiety with the French-Canadian version of the State-Trait Anxiety Inventory for Children (STAIC-F) and the Child Fear Scale (CFS, 0-4). Physiological biomarkers of anxiety such as alpha-amylase and other markers such as heart rate and head deviation will also be measured. Measures of healthcare professionals, parents, and participants' level of satisfaction will also be collected. Analyses will be carried out according to the intention-to-treat principle, with a significance level (α) of 0.05. Discussion: Our study provides an alternative method for anxiety management to better prepare patients for an awake MRI. It will guide future medical practice by providing evidence-based knowledge on a non-pharmacological therapeutic modality for anxiety management in children scheduled for an MRI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 27, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

December 11, 2023

Status Verified

December 1, 2023

Enrollment Period

2.6 years

First QC Date

April 4, 2023

Last Update Submit

December 4, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Level of state-trait anxiety

    Anxiety level will be measured using the State-Trait Anxiety Inventory for Children (French-Canadian Version) (STAIC-F), a 40-item questionnaire separated equally into two parts (State \& Trait) tailored for assessing anxiety in children. Each of the questions (items) use a 0-4 scale where 0 is ''Almost never'' and 4 is ''Almost all the time''. The First part (first 20 questions) of the questionnaire measures the State (situational) anxiety of a specific situation and will be measured at T0, T1 and T2. The Second part (last 20 questions) measure the trait anxiety of the person and will only be measured at T0.

    Change from Baseline (T0) at 15 minutes (T1) and at 30 minutes (T2)

  • Level of anxiety

    Will also be assessed using the Child Fear Scale (CFS). 0 (no fear/anxiety) through 4 (extremely fearful/anxious).

    Change from Baseline (T0) at 15 minutes (T1) and at 45 minutes (T2)

Secondary Outcomes (12)

  • Sense of presence/engagement

    Measured after in intervention - 15 minutes (T1)

  • Head deviation in space

    Measured for the duration of the VR simulation for an approximate duration of 15 minutes (From T0 to T1)

  • Heart rate

    Measured at baseline (T0), immediately after the VR intervention has ended at 15 minutes (T1), and measured after the MRI at 45 minutes (T2)

  • Oxygen Saturation

    Measured at baseline (T0), immediately after the VR intervention has ended at 15 minutes (T1), and measured after the MRI at 45 minutes (T2)

  • Parent's satisfaction

    Measured at 45 minutes (T2)

  • +7 more secondary outcomes

Study Arms (2)

Virtual Reality Distraction

EXPERIMENTAL

Use of Virtual Reality (VR) before the MRI.

Device: Virtual Reality

Standard Treatment

ACTIVE COMPARATOR

Standard Treatment used at the radiology department.

Other: Standard Protocol

Interventions

The pre-procedural IVR game preparation (IMAGINE) was developed by Paperplane Therapeutics® (intervention development team). IMAGINE is an immersive virtual reality simulation aiming to reduce the anxiety and phobic reactions of young patients and to better prepare them for this exam. Since the game is a preparation, it is a no success game and is independent of the ability and previous experience of the child with video games. It offers an immersive and fun simulation that aims to desensitize young patients to MRI and transform an anxiety-inducing experience into a fun play session. The participant will learn about the main principles of magnetic resonance imaging and experience a very realistic simulation of the MRI exam. This will allow children to prepare for the MRI scanner by enabling them to experience the process of undergoing an MRI exam beforehand.

Virtual Reality Distraction

The usual care group will only receive the standard preparation, which comprises of an explanation of the MRI procedure given by the radiology technician as per the radiology department's protocol. Specifically at the hospital (HSJ), standard care also includes access to a television mounted near the MRI playing videos.The research nurse will be able to complete any information should they find it incomplete or substandard.

Standard Treatment

Eligibility Criteria

Age7 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • aged from 7 to 17 years old
  • required to undergo MRI
  • accompanied by a consenting parent or legal guardian who can understand, read and write either French or English

You may not qualify if:

  • have a diagnosis of epilepsy or any other condition preventing them from playing a virtual reality game
  • cannot stand a sitting or semi-upright sitting position (Fowler's position) during the preparation as the VR gear requires an angle of at least 30 degrees for head-tracking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Justine's Hospital

Montreal, Quebec, H1T 3C5, Canada

RECRUITING

MeSH Terms

Conditions

Anxiety Disorders

Interventions

AIEOP acute lymphoblastic leukemia protocol

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Sylvie Le May, PhD

    St. Justine's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sylvie Le May, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 4, 2023

First Posted

June 18, 2023

Study Start

May 27, 2022

Primary Completion

December 30, 2024

Study Completion

June 30, 2025

Last Updated

December 11, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations